Market Data 
Markets
Replies to post #39098 on Biotech Values
01/10/12 9:05 AM
Eli Lilly decided to adopt its new [softer] approach after watching launches of new drugs like Strattera for attention deficit-hyperactivity disorder and the blood thinner Effient stumble, according to Mr. Ricks. One possible problem the company identified was a mismatch between what doctors expected based on sales pitches, and what the products delivered. [LOL. Effient may yet do ok, but Strattera simply doesn’t have much efficacy.]
Now, the company's sales team draws marketing lessons from how Disney keeps families coming to its amusement parks. Lilly's most recent national sales meeting, held at Disney's business training institute in Florida in February, was devoted to customer service, not product training. Sales representatives watched how Animal Kingdom workers greeted families at the gate and answered questions around the attractions [LMAO].
AI
